Competing interests
Johnson & Johnson, Boehringer
AEL does not declare any conflicts of interest. CLR declares grants to his institution from the Irish Research Council, Health Research Board, Science Foundation Ireland and Anabio; consulting fees from NovoNordisk, Eli Lily, Johnson & Johnson, Boehringer Ingelheim, GI dynamics and Herbalife; Honoraria for presentations and support for attending meetings from NovoNordisk, Herbalife and Johnson & Johnson; unpaid leadership roles for the Irish Society for Nutrition and Metabolism and stocks in Keyron. BM is a shareholder in Reset Health and also performs Advisory and educational work for Novonordisk and Advisory work for Lilly. DP declares honoraria and consulting fees from Johnson & Johnson, honoraria from Medtronic and NovoNordisk and unpaid leadership roles at the Royal College of Surgeons, England. All other authors do not declare any conflicts of interest.